Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 6/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.39 |
| ▸ | SIRT3 | Q9NTG7 | 6/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12572156 | 1.00 | SIRT2 (0.39) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435394 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL12572161 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435387 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435397 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435393 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435352 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435389 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435396 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 | |
| SCHEMBL13435399 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT3ADAM17TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100075895-A1 | Cyclic Natriuretic Peptide Constructs | PALATIN TECHNOLOGIES, INC. (US) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100075895-A1 | Cyclic Natriuretic Peptide Constructs | NPR1, NPR3, NPPA | SIRT2 4300/4885SIRT1 3674/4885SIRT3 4180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.